✦ LIBER ✦

A Randomized Trial to Evaluate the Relative Protection Against Post-Percutaneous Coronary Intervention Microvascular Dysfunction, Ischemia, and Inflammation Among Antiplatelet and Antithrombotic Agents: The PROTECT–TIMI-30 Trial

✍ Scribed by C. Michael Gibson; David A. Morrow; Sabina A. Murphy; Theresa M. Palabrica; Lisa K. Jennings; Peter H. Stone; Henry H. Lui; Thomas Bulle; Nasser Lakkis; Richard Kovach; David J. Cohen; Polly Fish; Carolyn H. McCabe; Eugene Braunwald

Book ID: 119265798
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 209 KB
Volume: 47
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2005.12.077

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association between Thrombolysis In Myoc

Association between Thrombolysis In Myocardial Infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: Observations from the Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Antiplatelet and Antithrombotic Agents–Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30)

✍ C. Michael Gibson; Ajay J. Kirtane; David A. Morrow; Theresa M. Palabrica; Sabin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 156 KB